Published in Neurology on November 01, 1987
The role of laboratory investigation in the diagnosis and management of patients with suspected herpes simplex encephalitis: a consensus report. The EU Concerted Action on Virus Meningitis and Encephalitis. J Neurol Neurosurg Psychiatry (1996) 1.87
Two cases of necrotizing myelopathy associated with malignancy caused by herpes simplex virus type 2. Acta Neuropathol (1989) 1.53
Herpes latency, meningitis, radiculomyelopathy and disseminated infection. Genitourin Med (1994) 0.87
Acute lumbosacral polyradiculopathy due to cytomegalovirus in advanced HIV disease: CSF findings in 17 patients. J Neurol Neurosurg Psychiatry (1996) 0.81
Herpes simplex virus type 2 ascending myeloradiculitis: MRI findings and rapid diagnosis by the polymerase chain method. J Neurol Neurosurg Psychiatry (1994) 0.78
Vanishing spinal cord after varicella-zoster virus myelitis. Neurol Neuroimmunol Neuroinflamm (2017) 0.75
Hyperaesthesia following genital herpes: a case report. Dermatol Res Pract (2011) 0.75
Retrospective diagnosis of fatal herpes simplex myelitis by immunocytochemistry and polymerase chain reaction. J Neurol Neurosurg Psychiatry (1994) 0.75
Ascending myelitis. BMJ Case Rep (2009) 0.75
Elsberg syndrome: A rarely recognized cause of cauda equina syndrome and lower thoracic myelitis. Neurol Neuroimmunol Neuroinflamm (2017) 0.75
A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N Engl J Med (1997) 7.56
A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group. N Engl J Med (1992) 5.93
Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord (1997) 4.31
Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study. JAMA (2000) 3.99
Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2001) 3.74
Epidermal growth factor and fibroblast growth factor-2 have different effects on neural progenitors in the adult rat brain. J Neurosci (1997) 3.61
Clinical dementia rating training and reliability in multicenter studies: the Alzheimer's Disease Cooperative Study experience. Neurology (1997) 3.53
Proliferation and differentiation of progenitor cells throughout the intact adult rat spinal cord. J Neurosci (2000) 3.40
Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, Part XV. Neurology (1996) 3.23
Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma. J Clin Invest (1996) 3.10
Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies. Neurology (2003) 3.07
Comparisons of verbal fluency tasks in the detection of dementia of the Alzheimer type. Arch Neurol (1992) 3.04
A validation study of the Dementia Questionnaire. Arch Neurol (1994) 2.89
A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study. Neurology (2000) 2.76
Nucleus basalis and thalamic control of neocortical activity in the freely moving rat. J Neurosci (1988) 2.73
Genetic evidence for the involvement of tau in progressive supranuclear palsy. Ann Neurol (1997) 2.60
Small concomitant vascular lesions do not influence rates of cognitive decline in patients with Alzheimer disease. Arch Neurol (2000) 2.37
In dementia with Lewy bodies, Braak stage determines phenotype, not Lewy body distribution. Neurology (2007) 2.24
Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides. Science (1989) 2.19
Treatment of agitation in AD: a randomized, placebo-controlled clinical trial. Neurology (2000) 2.10
Neurocognitive impairment is an independent risk factor for death in HIV infection. San Diego HIV Neurobehavioral Research Center Group. Arch Neurol (1997) 2.00
Cognitive decline is faster in Lewy body variant than in Alzheimer's disease. Neurology (1998) 1.96
Incidence of and risk factors for hallucinations and delusions in patients with probable AD. Neurology (2000) 1.91
Clinical-neuropathological correlations in Alzheimer's disease and related dementias. Arch Neurol (1994) 1.90
The importance of neuritic plaques and tangles to the development and evolution of AD. Neurology (2004) 1.87
Secretion of beta-amyloid precursor protein cleaved at the amino terminus of the beta-amyloid peptide. Nature (1993) 1.85
Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease. Proc Natl Acad Sci U S A (1997) 1.80
Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment. Neurology (2008) 1.80
Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease. Neurology (2004) 1.74
Alzheimer's disease can be accurately diagnosed in very mildly impaired individuals. Neurology (2002) 1.74
Diagnostic accuracy of dementia with Lewy bodies. Arch Neurol (2000) 1.69
Essential role of neocortical acetylcholine in spatial memory. Nature (1995) 1.68
Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment. Neurology (2007) 1.67
Neuropsychological function and apolipoprotein E genotype in the preclinical detection of Alzheimer's disease. Psychol Aging (1999) 1.66
The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant. Neurology (1996) 1.64
Neurofibrillary tangles in progressive supranuclear palsy. Electron microscopic observations. J Neuropathol Exp Neurol (1974) 1.60
Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer's disease. Neurology (1997) 1.58
Cholinergic dysfunction in diseases with Lewy bodies. Neurology (2000) 1.58
Neurochemical markers do not correlate with cognitive decline in the Lewy body variant of Alzheimer disease. Arch Neurol (1999) 1.56
Nerve regeneration in silicone chambers: influence of gap length and of distal stump components. Exp Neurol (1982) 1.56
Clinical features and changing patterns of neurodegenerative disorders on Guam, 1997-2000. Neurology (2002) 1.55
Monitoring progression in Alzheimer's disease. J Am Geriatr Soc (1991) 1.55
The Mini-Mental State Examination in the early diagnosis of Alzheimer's disease. Arch Neurol (1990) 1.55
The severe impairment battery: concurrent validity and the assessment of longitudinal change in Alzheimer's disease. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord (1997) 1.53
Intraparenchymal infusions of 192 IgG-saporin: development of a method for selective and discrete lesioning of cholinergic basal forebrain nuclei. J Neurosci Methods (1999) 1.52
Cognitive profiles differ in autopsy-confirmed frontotemporal dementia and AD. Neurology (2002) 1.49
Cycad exposure and risk of dementia, MCI, and PDC in the Chamorro population of Guam. Neurology (2007) 1.48
Episodic memory changes are associated with the APOE-epsilon 4 allele in nondemented older adults. Neurology (1995) 1.42
Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology. Neurology (2003) 1.42
Spatial-temporal progress of peripheral nerve regeneration within a silicone chamber: parameters for a bioassay. J Comp Neurol (1983) 1.39
Longitudinal evaluation of dementia of the Alzheimer type: a comparison of 3 standardized mental status examinations. Neurology (1990) 1.38
Experimental syphilitic orchitis in rabbits: ultrastructural appearance of Treponema pallidum during phagocytosis and dissolution by macrophages in vivo. Lab Invest (1982) 1.37
Neuropsychological deficits associated with diffuse Lewy body disease. Brain Cogn (1996) 1.36
A multicenter evaluation of new treatment efficacy instruments for Alzheimer's disease clinical trials: overview and general results. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord (1997) 1.36
Neonatal infection with the Daniels strain of Theiler's murine encephalomyelitis virus. Lab Invest (1983) 1.34
Hippocampal sclerosis contributes to dementia in the elderly. Neurology (1997) 1.34
Glycogen accumulation in the nerves and kidney of chronically diabetic rats. A quantitative electron microscopic study. J Neuropathol Exp Neurol (1979) 1.30
Clinical failure of CMV retinitis with intravitreal cidofovir is associated with antiviral resistance. Arch Ophthalmol (1998) 1.29
Alzheimer's disease: a correlational analysis of the Blessed Information-Memory-Concentration Test and the Mini-Mental State Exam. Neurology (1986) 1.28
Structural and functional neuropathology in transgenic mice with CNS expression of IFN-alpha. Brain Res (1999) 1.28
Neurotoxicity of local anesthetics: altered perineurial permeability, edema, and nerve fiber injury. Anesthesiology (1986) 1.26
Evolution of neuropathologic abnormalities associated with blood-brain barrier breakdown in transgenic mice expressing interleukin-6 in astrocytes. J Neuropathol Exp Neurol (1995) 1.24
Assessment of agitation in Alzheimer's disease: the agitated behavior in dementia scale. Alzheimer's Disease Cooperative Study. J Am Geriatr Soc (1999) 1.22
Cerebral infarction in Alzheimer's disease is associated with severe amyloid angiopathy and hypertension. Arch Neurol (1995) 1.22
Prevalence of dementia in Chamorros on Guam: relationship to age, gender, education, and APOE. Neurology (2007) 1.22
Diagnostic validity of the dementia questionnaire for Alzheimer disease. Arch Neurol (1998) 1.22
Pathology of experimental nerve compression. Lab Invest (1986) 1.19
Expression pattern of synucleins (non-Abeta component of Alzheimer's disease amyloid precursor protein/alpha-synuclein) during murine brain development. J Neurochem (1998) 1.18
Clinical validity of the Mattis Dementia Rating Scale in detecting Dementia of the Alzheimer type. A double cross-validation and application to a community-dwelling sample. Arch Neurol (1995) 1.18
Microangiopathy in human diabetic neuropathy. Acta Neuropathol (1985) 1.17
Myasthenia gravis-like syndrome induced by expression of interferon gamma in the neuromuscular junction. J Exp Med (1995) 1.17
Association between severe cerebral amyloid angiopathy and cerebrovascular lesions in Alzheimer disease is not a spurious one attributable to apolipoprotein E4. Arch Neurol (2000) 1.15
Low body weight in Alzheimer's disease is associated with mesial temporal cortex atrophy. Neurology (1996) 1.14
The proto-oncogene c-fos is over-expressed in the majority of human osteosarcomas. Oncogene (1990) 1.14
Death certificate reporting of dementia and mortality in an Alzheimer's disease research center cohort. J Am Geriatr Soc (1995) 1.14
Abnormal verbal event related potentials in mild cognitive impairment and incipient Alzheimer's disease. J Neurol Neurosurg Psychiatry (2002) 1.13
Diagnosis and evaluation of dementia. Neurology (1995) 1.13
Assessing patterns of agitation in Alzheimer's disease patients with the Cohen-Mansfield Agitation Inventory. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord (1997) 1.12
Comparison of the serial position effect in very mild Alzheimer's disease, mild Alzheimer's disease, and amnesia associated with electroconvulsive therapy. J Int Neuropsychol Soc (2000) 1.11
Cognitive profiles of autopsy-confirmed Lewy body variant vs pure Alzheimer disease. Arch Neurol (1998) 1.10
Early changes in experimental allergic neuritis. Lab Invest (1983) 1.09
Comparison of rate of annual change of mental status score in four independent studies of patients with Alzheimer's disease. Ann Neurol (1988) 1.09
Distinguishing normal and demented elderly with the selective reminding test. J Clin Exp Neuropsychol (1989) 1.08
Microangiopathy of vasa nervorum in dysglobulinemic neuropathy. Ann Neurol (1984) 1.07
Mapping of the major histocompatibility complex and viral antigens on the plasma membrane of a measles virus-infected cell. Virology (1983) 1.07
Immune response to hepaitis virus type B in Down's syndrome and other mentally retarded patients. Am J Epidemiol (1972) 1.07
Pressure increase in the dorsal root ganglion following mechanical compression. Closed compartment syndrome in nerve roots. Spine (Phila Pa 1976) (1989) 1.07
Late-onset chronic inflammatory encephalopathy in immune-competent and severe combined immune-deficient (SCID) mice with astrocyte-targeted expression of tumor necrosis factor. Am J Pathol (1998) 1.07
Reactive, degenerative, and proliferative Schwann cell responses in experimental galactose and human diabetic neuropathy. Acta Neuropathol (1998) 1.06
Abeta1-42 promotes cholinergic sprouting in patients with AD and Lewy body variant of AD. Neurology (2003) 1.05
Monoclonal antibody defines determinant between Theiler's virus and lipid-like structures. J Neuroimmunol (1988) 1.05
Mini-Mental State Examination and Mattis Dementia Rating Scale performance differs in Hispanic and non-Hispanic Alzheimer's disease patients. J Int Neuropsychol Soc (1999) 1.05
Oral physostigmine and lecithin improve memory in Alzheimer disease. Ann Neurol (1983) 1.05
Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease. Int Clin Psychopharmacol (2003) 1.04
Repeated exposure to the Mini-Mental State Examination and the Information-Memory-Concentration Test results in a practice effect in Alzheimer's disease. Neurology (1993) 1.03
Clinical features distinguishing large cohorts with possible AD, probable AD, and mixed dementia. J Am Geriatr Soc (1993) 1.03
Histomorphometric analysis of optic nerve changes in experimental glaucoma. J Glaucoma (1999) 1.03
Nursing home placement is related to dementia progression: experience from a clinical trial. Alzheimer's Disease Cooperative Study. Neurology (1999) 1.02
Transgenic models to assess the pathogenic actions of cytokines in the central nervous system. Mol Psychiatry (1997) 1.00
Changes in endoneurial fluid pressure, permeability, and peripheral nerve ultrastructure in experimental lead neuropathy. Ann Neurol (1980) 1.00